In a breakthrough that challenges long-held conventions in organic synthesis, researchers have successfully created a class ...

EyePoint's Duravyu, a potential "best-in-class" therapy for Wet AMD and DME, could disrupt the market with fewer injections ...

09/2015 - 08/2020 Ph.D. in Peking University, advisor: Prof. Yong Huang, Shenzhen, P. R. China 09/2011 - 07/2015 B.Sc. in Clinical Pharmacy, School of pharmacy ...

Provided herein are novel bicyclic amines as CDK2 inhibitors, pharmaceutical compositions, use of such compounds in treating metastatic breast cancer or metastatic lung cancer and processes for ...